Accelerate Diagnostics Stock News

Accelerate Diagnostics Inc (NASDAQ:AXDX) was the target of unusually large options trading activity on Thursday. Traders purchased 1,713 put options on the stock. This represents an increase of 1,416%

Market Segmentation & Coverage: This research report categorizes the Cell Isolation/Cell Separation to forecast the revenues and analyze the trends in each of the following sub-markets:

MENLO PARK, Calif.--(BUSINESS WIRE)--AST Private Company Solutions™ (AST PCS) today introduced a new strategic partnership with Liquid Stock, the venture capital-like investment fund providing bespo

In terms of safety of use, the profile of the molecule appeared to be "globally favorable" and in line with the observations of previous clinical studies.

Stocks Analysis by Harry Boxer covering: Bed Bath & Beyond Inc, Target Corporation, United States Steel Corporation, Celsion Corp. Read Harry Boxer's latest article on Investing.com

The outlook for toll roads, airports, gas pipelines and electricity networks is likely to be patchy until a COVID-19 vaccine is found, which at the very earliest could be in mid-2021. Energy networks

16 Jun 2020 - The ASX shot up at the open and is now tracking almost 3.2% higher at noon. Almost all the top 200 stocks have made gains today. Viva Energy saw their shares rise today after releasing t

Steris reported a record fiscal year for earnings supported by its leadership position in sterilization products and services. The company expects some near-ter

Alice Feeney’s (Sometimes I Lie) latest thriller novel His & Hers is in the works for the small screen. Jessica Chastain’s Freckle Films, Kristen Campo (The Killing, The L- Word), and End…

(BFM Bourse) - La biotech bourguignonne a annoncé lundi le succès sur différents critères d'efficacité de sa molécule lanifibranor pour soigner les …

Steris and Fortive are on the rise, thanks in part to their medical devices used to decontaminate N95 or N95-equivalent respirators.

NEW YORK, June 15, 2020 -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Accelerate Diagnostics, Inc. (“Accelerate.